vs
Side-by-side financial comparison of DNA X, Inc. (SONM) and Stereotaxis, Inc. (STXS). Click either name above to swap in a different company.
DNA X, Inc. is the larger business by last-quarter revenue ($16.2M vs $8.6M, roughly 1.9× Stereotaxis, Inc.). DNA X, Inc. runs the higher net margin — -29.3% vs -64.0%, a 34.7% gap on every dollar of revenue. On growth, Stereotaxis, Inc. posted the faster year-over-year revenue change (36.3% vs 7.9%). Over the past eight quarters, Stereotaxis, Inc.'s revenue compounded faster (12.1% CAGR vs 9.9%).
Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures.
SONM vs STXS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.2M | $8.6M |
| Net Profit | $-4.8M | $-5.5M |
| Gross Margin | 11.2% | 50.1% |
| Operating Margin | -24.5% | -65.4% |
| Net Margin | -29.3% | -64.0% |
| Revenue YoY | 7.9% | 36.3% |
| Net Profit YoY | -89.2% | 26.4% |
| EPS (diluted) | $-4.83 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $8.6M | ||
| Q3 25 | $16.2M | $7.5M | ||
| Q2 25 | $11.2M | $8.8M | ||
| Q1 25 | $16.7M | $7.5M | ||
| Q4 24 | $15.3M | $6.3M | ||
| Q3 24 | $15.0M | $9.2M | ||
| Q2 24 | $11.5M | $4.5M | ||
| Q1 24 | $9.1M | $6.9M |
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $-4.8M | $-6.5M | ||
| Q2 25 | $-7.5M | $-3.8M | ||
| Q1 25 | $458.0K | $-5.8M | ||
| Q4 24 | $-21.6M | $-7.5M | ||
| Q3 24 | $-2.5M | $-6.2M | ||
| Q2 24 | $-6.6M | $-5.8M | ||
| Q1 24 | $-2.9M | $-4.5M |
| Q4 25 | — | 50.1% | ||
| Q3 25 | 11.2% | 54.9% | ||
| Q2 25 | 7.6% | 52.0% | ||
| Q1 25 | 50.0% | 54.4% | ||
| Q4 24 | -1.2% | 50.7% | ||
| Q3 24 | 28.2% | 44.6% | ||
| Q2 24 | 25.8% | 73.6% | ||
| Q1 24 | 31.8% | 57.6% |
| Q4 25 | — | -65.4% | ||
| Q3 25 | -24.5% | -87.8% | ||
| Q2 25 | -60.2% | -45.2% | ||
| Q1 25 | 3.9% | -79.3% | ||
| Q4 24 | 55.3% | -120.3% | ||
| Q3 24 | -15.8% | -69.0% | ||
| Q2 24 | -56.2% | -133.7% | ||
| Q1 24 | -29.5% | -69.0% |
| Q4 25 | — | -64.0% | ||
| Q3 25 | -29.3% | -86.6% | ||
| Q2 25 | -66.8% | -43.5% | ||
| Q1 25 | 2.7% | -77.9% | ||
| Q4 24 | -141.6% | -118.5% | ||
| Q3 24 | -16.7% | -67.3% | ||
| Q2 24 | -57.5% | -129.6% | ||
| Q1 24 | -31.9% | -65.5% |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $-4.83 | $-0.07 | ||
| Q2 25 | $-0.79 | $-0.05 | ||
| Q1 25 | $0.08 | $-0.07 | ||
| Q4 24 | $-116.99 | $-0.09 | ||
| Q3 24 | $-9.32 | $-0.08 | ||
| Q2 24 | $-1.41 | $-0.07 | ||
| Q1 24 | $-0.65 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.1M | $13.4M |
| Total DebtLower is stronger | $5.1M | — |
| Stockholders' EquityBook value | $-701.0K | $13.5M |
| Total Assets | $40.2M | $52.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.4M | ||
| Q3 25 | $2.1M | $10.5M | ||
| Q2 25 | $2.0M | $7.0M | ||
| Q1 25 | $2.1M | $10.6M | ||
| Q4 24 | $5.3M | $12.2M | ||
| Q3 24 | $9.1M | $10.7M | ||
| Q2 24 | $9.6M | $14.7M | ||
| Q1 24 | $9.3M | $17.6M |
| Q4 25 | — | — | ||
| Q3 25 | $5.1M | — | ||
| Q2 25 | $2.9M | — | ||
| Q1 25 | $2.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $13.5M | ||
| Q3 25 | $-701.0K | $6.3M | ||
| Q2 25 | $-1.3M | $1.5M | ||
| Q1 25 | $-1.1M | $2.9M | ||
| Q4 24 | $-5.7M | $6.1M | ||
| Q3 24 | $15.3M | $10.8M | ||
| Q2 24 | $17.5M | $11.4M | ||
| Q1 24 | $19.8M | $14.6M |
| Q4 25 | — | $52.3M | ||
| Q3 25 | $40.2M | $45.6M | ||
| Q2 25 | $36.1M | $41.2M | ||
| Q1 25 | $36.0M | $45.7M | ||
| Q4 24 | $39.7M | $46.7M | ||
| Q3 24 | $49.1M | $50.9M | ||
| Q2 24 | $45.9M | $36.0M | ||
| Q1 24 | $42.4M | $39.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.0M | $-4.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-4.0M | ||
| Q3 25 | $-7.0M | $-4.2M | ||
| Q2 25 | $-4.9M | $-3.7M | ||
| Q1 25 | $-9.6M | $-1.8M | ||
| Q4 24 | $-4.5M | $1.3M | ||
| Q3 24 | $-417.0K | $-4.3M | ||
| Q2 24 | $-3.4M | $-3.1M | ||
| Q1 24 | $-168.0K | $-2.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-4.5M | — | ||
| Q3 24 | $-554.0K | $-4.3M | ||
| Q2 24 | $-3.4M | — | ||
| Q1 24 | $-198.0K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -29.6% | — | ||
| Q3 24 | -3.7% | -47.2% | ||
| Q2 24 | -29.8% | — | ||
| Q1 24 | -2.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.9% | 0.1% | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -20.97× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SONM
Segment breakdown not available.
STXS
| Disposables Service And Accessories | $5.3M | 61% |
| Systems | $3.4M | 39% |
